Bioengineered Artificial Skin Market Propelled by Adoption of Regenerative Skin Treatments for Burn Injuries


The bioengineered artificial skin products provide protection against bacterial infections and dehydration in burn victims and promote healing through regeneration of skin tissues. Artificial skin products include pre-fabricated skin grafts and spray-on artificial skin which find widespread adoption in management of burn injuries.

The global Bioengineered Artificial Skin Market is estimated to be valued at US$ 1.9 billion in 2023 and is expected to exhibit a CAGR of 16.% over the forecast period 2023 to 2028, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The adoption of regenerative skin treatments has been propelling the growth of bioengineered artificial skin market. Regenerative skin treatments involve use of bioengineered artificial skin products that facilitate regeneration of healthy skin tissues in burn victims. These artificial skin grafts contain cells that regenerate into new skin tissues and also release growth factors to stimulate regeneration. They provide an ideal temporary protective covering over burns to prevent infections and promote healing through natural regeneration of skin cells. The capability of regenerative bioengineered artificial skin to facilitate generation of replacement skin tissues naturally through cell signaling molecules makes them increasingly adopted for treatment of severe burn injuries.

SWOT Analysis
Strength: Bioengineered artificial skin offers several advantages over conventional skin grafts. It can integrate well with the native skin and requires minimal invasive procedures.
Weakness: Their high production costs and lack of vascularization limit their widespread adoption. Further research is needed to optimize mechanical properties.
Opportunity: Rising burns and skin loss cases due to accidents, cancer, and genetic disorders widen the scope. Advancing regenerative techniques could help develop versatile skin substitutes.
Threats: Presence of alternatives like autologous skin grafts and stringent regulations for their approval may impede market dynamics.

Key Takeaways
The global bioengineered artificial skin market is expected to witness high growth.

Regional analysis: North America holds the largest share due to a rise in plastic surgeries, cosmetic procedures, technological advancements, and supportive reimbursement policies. Asia Pacific will be the fastest-growing region due to surging healthcare spending, skin disease prevalence, and government initiatives to enhance medical technologies.

Key players operating in the bioengineered artificial skin market are Stratatech Corporation, SPANCENT, Platelet BioGenesis, Tissue Regenix, and Smith & Nephew.


  1. Source: Coherent Market Insights, Public sources, Desk research

2. We have leveraged AI tools to mine information and compile it